Marinomed Biotech AG | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Marinomed Biotech AG

BRIEF

published on 10/06/2025 at 15:01, 1 month 29 days ago

Marinomed Biotech AG Explores Strategic Alternatives for Marinosolv Platform

Strategic Options Marinomed Biotech Biotech Innovation Marinosolv Platform Health Partnerships
PRESS RELEASE

published on 10/06/2025 at 14:56, 1 month 29 days ago

EQS-Adhoc: Marinomed Biotech AG begins reviewing strategic options for the Marinosolv platform
Marinomed Biotech AG initiates strategic review of Marinosolv platform following successful capital measures. Evaluation may include partnerships for Budesolv and Tacrosolv projects

Strategic Partnerships Marinomed Biotech AG Strategic Review Marinosolv Platform Capital Measures
BRIEF

published on 10/01/2025 at 12:23, 2 months 3 days ago

Marinomed Biotech AG: First Berlin Equity Reiterates Buy Rating

Financial Results Buy Recommendation Capital Increase Marinomed Biotech AG Licensing Deals
PRESS RELEASE

published on 10/01/2025 at 12:18, 2 months 3 days ago

Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirmed a Buy rating and EUR 50.00 price target for Marinomed Biotech AG. H1 results were in line with expectations, with nearly tripled sales and positive AEBITDA amid strategic financial moves

First Berlin Equity Research BUY Rating Marinomed Biotech AG H1 Results EUR 50.00 Price Target
BRIEF

published on 09/17/2025 at 13:53, 2 months 17 days ago

Marinomed Biotech AG Reports Significant Growth in H1 2025

Financial Results Revenue Increase EBIT Growth Capital Measures Biotech Growth
PRESS RELEASE

published on 09/17/2025 at 13:48, 2 months 17 days ago

Marinomed Biotech AG announces results for the first half year of 2025
Marinomed Biotech AG reports strong financial results for the first half of 2025, with revenues of EUR 7.2 million and EBIT of EUR 21.0 million. The company secured financing through capital measures

Revenues Financial Results EBIT Marinomed Biotech AG Capital Measures
BRIEF

published on 09/16/2025 at 15:27, 2 months 18 days ago

Marinomed Biotech AG Announces Capital Increase

Investment Biotech Industry Capital Increase Share Issuance Marinomed Biotech AG
PRESS RELEASE

published on 09/16/2025 at 15:22, 2 months 18 days ago

EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 61.607 no-par value bearer shares at an issue price of EUR 17,50 per share
Marinomed Biotech AG resolves capital increase by issuing 61.607 bearer shares at EUR 17,50 per share, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Subscription Rights Bearer Shares EUR 17,50
BRIEF

published on 09/01/2025 at 12:01, 3 months 3 days ago

Marinomed Biotech AG Secures EUR 2.5 Million Convertible Bond Agreement

Financing Investment Strategy Shareholder Rights Convertible Bond Marinomed Biotech
PRESS RELEASE

published on 09/01/2025 at 11:56, 3 months 3 days ago

EQS-Adhoc: Marinomed Biotech AG: Agreement on the key terms of the issue of a secured EUR 2.5mn convertible bond
Marinomed Biotech AG announces agreement on key terms for a secured EUR 2.5mn convertible bond issue, including interest rate and conversion price

Marinomed Biotech AG Convertible Bond Secured EUR 2.5mn Key Terms

Accesswire

Published on 12/05/2025 at 02:35, 1 hour 58 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 3 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 3 hours 33 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 28 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 33 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 2 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 42 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 7 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 18 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 22 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 10 hours 33 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 48 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 48 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 32 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE